Lumentum

No trajectory update has cleared publication yet.

• The filing does not state the sales' purpose or the officer's tax or liquidity circumstances.
• The packet does not provide Lumentum operating results or valuation context.
• The packet does not state whether the sales are connected to the separate Rule 144 notices.
• Yuen's remaining direct and indirect holdings after the reported transactions.
• Whether additional plan sales are scheduled.
• The packet does not confirm execution of the proposed August 31 sale.
• The packet does not provide net proceeds or tax treatment.
• The packet does not provide a single consolidated figure for all Lumentum executive sales or proceeds.
• The filings do not state the portion of sales attributable to taxes, planned diversification or other personal liquidity needs.
• The packet does not provide the underlying award grant values or the exact vesting dates for each reported award.
• The packet does not confirm execution of the proposed August 28 sale.
• The notice does not state net proceeds or tax treatment.
• Whether either proposed sale on 08/27/2026 was completed.
• The post-transaction holdings of Yuen and Hurlston.
• The dollar proceeds actually realized, if different from the stated aggregate market values.
• The business, tax, liquidity, or diversification reasons for the proposed sales.
• Whether additional insiders or affiliated persons made related filings not included in this event packet.
• The filing does not identify Customer A or Customer B by name, so customer-specific exposure cannot be independently assessed from this packet.
• The packet does not provide market reaction or investor interpretation of the debt exchanges.
• The ultimate cash-versus-equity settlement mix for future conversion requests is not fully determined; the filing states that conversion value above principal may be settled in cash, shares or a combination at Lumentum’s election.
• The filing does not quantify the future revenue contribution or profitability of the Greensboro manufacturing facility and its transitional supply agreement beyond the approximately $2.3 million of below-market-contract revenue recognized during fiscal 2026.
• The packet does not identify Retort's successor or interim replacement.
• The packet does not disclose the value or number of equity awards that will continue vesting.
• The packet does not disclose the consulting fee or other terms.
• The exchange fund's assets, fees, restrictions, and eventual share-delivery terms are not disclosed in the packet.
• The packet does not state whether the transfer has tax consequences or whether any cash changed hands.
• The eventual value of the exchange-fund shares is unknown.
• Prior beneficial ownership and the amount or direction of any change.
• The transactions, dates and prices underlying the reported position.
• The proportion of the position held by particular client accounts.
• Whether the exchange transactions closed on or about June 4, 2026.
• The final number of shares issued and the final principal amount of notes cancelled.
• The final amount of 2028 notes outstanding after all early conversion requests and settlement activity.
• Any accounting gain, loss, expense, or other income-statement effect from the exchange transactions.
• The filing does not provide customer names for the customers accounting for 26% and 12% of quarterly revenue.
• The filing does not quantify the capacity increase expected from the Greensboro facility or the timing at which expanded capacity will become operational.
• The filing does not establish how long elevated AI and cloud demand will persist or whether current supply constraints will translate into comparable future revenue growth.
• The filing reports early conversion requests and subsequent note exchanges, but the ultimate cash requirement and final dilution from all convertible-note activity remain uncertain.
• Whether the exchange closed on or about April 13, 2026.
• The final number of shares issued and the exact conversion value above principal.
• The transaction's accounting impact and effect on interest expense, if any.
• The final fully diluted share count after the exchange.
• Use of the $2 billion cash proceeds.
• The applicable conversion waiting-period timing and whether or when conversion will occur.
• The percentage of Lumentum common stock represented by the potential conversion shares.
• Any commercial commitments, order value, milestones, or expected revenue from the strategic partnership.
• Final terms and details in the Securities Purchase Agreement, Certificate of Designation, and joint press release.
• The packet does not include a later confirmation of execution, final sale price, or net proceeds.
• Whether the exchange transactions actually closed on or about June 4, 2026.
• The final post-closing aggregate principal amount of 2028 notes after all early conversion requests and settlement activity.
• The final post-closing diluted share count and any accounting gain, loss or expense recognized on the exchange.
• The packet does not disclose the reason for Sepe's retirement beyond the planned retirement statement.
• The packet does not provide Chang's compensation details beyond saying it is not expected to change.
• The packet does not disclose whether the transition will affect financial reporting, controls or the timing of the next quarterly filing.